JP2008531693A - 局所用ゲル組成物 - Google Patents

局所用ゲル組成物 Download PDF

Info

Publication number
JP2008531693A
JP2008531693A JP2007558091A JP2007558091A JP2008531693A JP 2008531693 A JP2008531693 A JP 2008531693A JP 2007558091 A JP2007558091 A JP 2007558091A JP 2007558091 A JP2007558091 A JP 2007558091A JP 2008531693 A JP2008531693 A JP 2008531693A
Authority
JP
Japan
Prior art keywords
composition
nsaid
alcohol
amount
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531693A5 (OSRAM
Inventor
スパン−ウェイド，モニカ
ウォード，アンソニー，ジェイ．
Original Assignee
アイ エス ダブリュ グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by アイ エス ダブリュ グループ インコーポレイテッド filed Critical アイ エス ダブリュ グループ インコーポレイテッド
Publication of JP2008531693A publication Critical patent/JP2008531693A/ja
Publication of JP2008531693A5 publication Critical patent/JP2008531693A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2007558091A 2005-03-03 2006-02-27 局所用ゲル組成物 Pending JP2008531693A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US68110205P 2005-05-13 2005-05-13
US69020105P 2005-06-14 2005-06-14
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
PCT/US2006/006780 WO2006096360A1 (en) 2005-03-03 2006-02-27 Topical gels compositions

Publications (2)

Publication Number Publication Date
JP2008531693A true JP2008531693A (ja) 2008-08-14
JP2008531693A5 JP2008531693A5 (OSRAM) 2009-04-09

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007558091A Pending JP2008531693A (ja) 2005-03-03 2006-02-27 局所用ゲル組成物

Country Status (10)

Country Link
EP (1) EP1858503B1 (OSRAM)
JP (1) JP2008531693A (OSRAM)
KR (1) KR20080008321A (OSRAM)
AU (1) AU2006220964A1 (OSRAM)
BR (1) BRPI0608077A2 (OSRAM)
CA (1) CA2599968A1 (OSRAM)
ES (1) ES2437201T3 (OSRAM)
IL (1) IL185531A0 (OSRAM)
MX (1) MX2007010681A (OSRAM)
WO (1) WO2006096360A1 (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
JP2014513132A (ja) * 2011-05-03 2014-05-29 アポニア ラボラトリーズ インコーポレイテッド イブプロフェンの経皮組成物およびその使用方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
JP5432716B2 (ja) 2006-10-17 2014-03-05 ヌーボ リサーチ インコーポレイテッド ジクロフェナクゲル
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
RU2505291C2 (ru) 2009-06-24 2014-01-27 СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи Топическая композиция, содержащая ибупрофен
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) * 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
KR101141938B1 (ko) * 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
ES2811515T3 (es) 2010-12-29 2021-03-12 Strategic Science & Tech Llc Tratamiento de disfunción eréctil y otras indicaciones
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
KR20170023776A (ko) 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
KR20180134856A (ko) 2016-02-09 2018-12-19 루마 세러퓨틱스 인코포레이티드 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치
WO2019014299A1 (en) * 2017-07-11 2019-01-17 University Of Miami TOPICAL FORMULATIONS OF ACETAMINOPHENE FOR RELIEF RELIEF
EP4210714A4 (en) * 2020-05-19 2025-01-29 Mig Usa, Llc TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791913A (en) * 1980-11-28 1982-06-08 Nitto Electric Ind Co Ltd Pharmaceutical preparation of drug
JPH04210914A (ja) * 1990-01-24 1992-08-03 Mcneil Ppc Inc 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791913A (en) * 1980-11-28 1982-06-08 Nitto Electric Ind Co Ltd Pharmaceutical preparation of drug
JPH04210914A (ja) * 1990-01-24 1992-08-03 Mcneil Ppc Inc 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
JP2014513132A (ja) * 2011-05-03 2014-05-29 アポニア ラボラトリーズ インコーポレイテッド イブプロフェンの経皮組成物およびその使用方法
US10821071B2 (en) 2011-05-03 2020-11-03 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
US11419814B2 (en) 2011-05-03 2022-08-23 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof

Also Published As

Publication number Publication date
IL185531A0 (en) 2008-01-06
MX2007010681A (es) 2007-12-07
WO2006096360A1 (en) 2006-09-14
AU2006220964A1 (en) 2006-09-14
ES2437201T3 (es) 2014-01-09
BRPI0608077A2 (pt) 2009-11-10
EP1858503A1 (en) 2007-11-28
KR20080008321A (ko) 2008-01-23
EP1858503B1 (en) 2013-09-04
CA2599968A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
US20100158993A1 (en) Topical Gel Compositions
EP1858503B1 (en) Topical gels compositions
CA2662434C (en) Topical nsaid compositions with increased solubility
AU670777B2 (en) Aqueous gel vehicles for retinoids
CA2697458C (en) Non-aqueous topical solution of diclofenac and process for preparing the same
US20140314815A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
US8815953B2 (en) Formulations of vitamin K analogs for topical use
JP2000501429A (ja) 局所治療用および化粧用製剤の組成物基剤
JPH04210914A (ja) 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
Salau et al. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats
US20110281947A1 (en) Methods of administering diclofenac compositions for treating photodamaged skin
KR20210053946A (ko) 피내 적용을 위한 신규한 국소 제형 및 그것의 용도
ZA200707357B (en) Detection of very virulent infectious bursal disease virus
CN101541321A (zh) 局部用组合物
CN101151028A (zh) 局部用凝胶组合物
HK1119058A (en) Topical gels compositions
RU2809702C2 (ru) Композиции напроксена для местного применения в форме геля

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120703